Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

FS Mennini; A Marcellusi; G Fabiano; F Platini; P Bossi

doi:10.1002/hed.25481

Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

FS Mennini
, A Marcellusi
, G Fabiano
, F Platini
, P Bossi

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	908-914
Journal	Head & Neck
Volume	41
Issue number	4
Early online date	24 Jan 2019
DOIs	https://doi.org/10.1002/hed.25481
Publication status	Published - 30 Apr 2019

Keywords

Health services research

Access to Document

10.1002/hed.25481

Marcellusi-A-42736-AAMAccepted author manuscript, 1.01 MBLicence: Unspecified

https://doi.org/10.1002/hed.25481

Cite this

@article{760adbc3deab4abe8c33b28394c285c1,

title = "Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer",

keywords = "Health services research",

author = "FS Mennini and A Marcellusi and G Fabiano and F Platini and P Bossi",

year = "2019",

month = apr,

day = "30",

doi = "10.1002/hed.25481",

language = "English",

volume = "41",

pages = "908--914",

journal = "Head \& Neck",

issn = "1043-3074",

publisher = "John Wiley \& Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

AU - Mennini, FS

AU - Marcellusi, A

AU - Fabiano, G

AU - Platini, F

AU - Bossi, P

PY - 2019/4/30

Y1 - 2019/4/30

KW - Health services research

U2 - 10.1002/hed.25481

DO - 10.1002/hed.25481

M3 - Article

C2 - 30680828

SN - 1043-3074

VL - 41

SP - 908

EP - 914

JO - Head & Neck

JF - Head & Neck

IS - 4

ER -